Search results
Singapore. At GSK, we unite science, technology and talent to get ahead of disease together. We prevent and treat disease with vaccines, specialty and general medicines investing in four core therapeutic areas: infectious diseases, HIV, respiratory/immunology, and oncology.
THE expansion of British drugmaker GSK’s facility at Tuas has earned it the title of Singapore’s largest vaccine production site based on a cumulative investment of some S$850 million, said Minister for Trade and Industry Gan Kim Yong.
Jul 13, 2023 · SINGAPORE - The expansion of British drugmaker GSK’s facility in Tuas has earned the title of Singapore’s largest vaccine production site based on a cumulative investment of some $850 million,...
GSK’s latest investment is a strong show of confidence in Singapore’s world-class infrastructure and skilled workforce for biopharmaceutical manufacturing. In addition to efforts in developing manufacturing leaders in Singapore, GSK has also been a steadfast partner to our research ecosystem.
Nov 17, 2022 · SINGAPORE - GSK officially opened its first high-potency manufacturing and test facility in Singapore on Thursday, with the capability to manufacture highly potent components for cancer...
Issued: 17 November 2022, Singapore GSK opens first-in-Singapore high potency manufacturing and testing facility for next generation cancer treatments • S$44m investment in the new high potency manufacturing facility and laboratory further strengthens Jurong site capabilities to launch new products more quickly
Jul 13, 2023 · Global biopharmaceutical powerhouse GSK is expanding its Tuas vaccines facility in Singapore and will begin producing drug substances for Hepatitis B vaccines when commercial production commences in 2027.
Nov 18, 2022 · Facility will manufacture a key ingredient for antibody drug conjugates (ADCs) GSK plc today announced the opening of a new, S$44 million high potency facility (HPF) in its strategic New Product Introduction site in Jurong, Singapore.
Oct 30, 2017 · SINGAPORE - British pharmaceutical giant GSK officially opened its Asia headquarters here on Monday (Oct 30). Called GSK Asia House, the facility in Rochester Park functions as the commercial...
GSK has invested over S$1.5 billion worth of fixed assets here, and more than 1,000 people work for the company in Singapore. We want to continue deepening our relationship with GSK, and are jointly developing a 10-year GSK-Singapore Strategic Roadmap.
